Fixing a market failure To develop new antibiotics upend the incentive structure experts urge
Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge
04:35 EDT 2 May 2019 |
STAT
“It’s a market failure that companies aren’t investing in antimicrobial resistance.”
More From BioPortfolio on "Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge"